Our mission is to help you obtain financial freedom. Checkout Our Youtube Channel Checkout Our Youtube Channel
Blog

MRNA Declines by 17% After Changes to Future Plans

Moderna announced plans to cut $1.1 billion in expenses by 2027 as it adapts to a post-COVID business environment. The company aims to win approval for 10 new products by 2027 but will also pause or scrap some projects to manage R&D spending. Moderna’s shares dropped by over 17% following the news, reflecting concerns about its financial position and delayed profitability until 2028. Despite these cuts, Moderna reported positive results for its vaccines, including respiratory syncytial virus (RSV) and flu shots, with plans to file for approvals. The company expects revenue growth from new product launches between 2026 and 2028. MRNA’s stock has suffered month after month decline, and is approaching a key support zone between $55.80 and $62.62. I would give MRNA some time to bottom out, and I would look for entries around $55-56.

Follow me on social media: https://linktr.ee/realchartchamp

0 Comments
Inline Feedbacks
View all comments

More ClearValue Insights

Default Thumbnail

Opportunity to Buy the TSLA Dip

Tesla held a We Robot event yesterday where Elon Musk unveiled some impressive products. TSLA’s stock price was bound to selloff whether the event was good or not. There has been an 8% decline, and I think this is a great opportunity for long-term Tesla investors to buy the dip. I think Tesla is facing […]

Read More
Default Thumbnail

NVDA Starting to Cool Down

NVDA has formed a bullish breakout above the light blue resistance line and has experienced a short term rally. I think the price is starting to cool down around $133 – $135, and I think it is likely that NVDA retests the light blue trendline as support around $123 – $124. Follow me on social […]

Read More
Default Thumbnail

HOLO Starting to Stabilize

HOLO has experienced a lot of intraday volatility after the reverse stock split took effect on Oct. 9. I think the price is starting to stabilize a bit around the $5.70 support level. I will still wait until the daily candle close today to see if the price holds above $5.70 or starts to trend […]

Read More